Dys-Immune Therapeutics

Science

IFN-α: a key regulator of immune balance.

Our platform is founded on a precise question: can modulation of persistent interferon-α signaling help restore more functional immunity?

The biological context

Essential in acute defense. Potentially disruptive when persistent.

Interferon-α is central to antiviral immunity. In chronic settings, sustained type-I interferon signaling has been associated with persistent immune activation and functional exhaustion.

01Healthy immune responseAcute antiviral sensing
02Controlled IFN-α activityTime-limited signaling
03Balanced immune functionCoordinated resolution

Chronic signaling

A different immunological state

01Chronic viral infectionPersistent antigenic pressure
02Sustained IFN-α signalingOngoing immune activation
03Immune dysfunctionExhaustion and impaired responses

The Dys-Immune approach

Modulate the pathway. Rebalance the system.

The platform is designed to modulate excessive IFN-α activity and may enable a more favorable immune environment. This is an investigational hypothesis supported by published biological evidence and now informing development.

01IFN-α modulation
02Reduced pathological signaling
03Potential restoration of immune balance

Beyond HIV

An immunological platform with broader potential

Beyond HIV, the platform may inform future programs across diseases characterized by dysregulated immune signaling. These are areas for scientific exploration, not active validated clinical programs.

Autoimmune disease
Viral infection
Oncology
Inflammatory disorders
Allergic disease
Neurodegenerative disease